Adalimumab Effectiveness Up to Six Years in Adalimumab-naïve Patients with Crohn’s Disease: Results of the PYRAMID Registry

V. Loftus, Edward; Reinisch, Walter; Panaccione, Remo; Berg, Sofie; Alperovich, Gabriela; Bereswill, Mareike; Kalabic, Jasmina; Petersson, Joel; Thakkar, Roopal; Robinson, Anne; D’Haens, Geert

doi:10.1093/ibd/izz008

Public

Adalimumab Effectiveness Up to Six Years in Adalimumab-naïve Patients with Crohn’s Disease: Results of the PYRAMID Registry

Published in Inflammatory Bowel Diseases • Feb 8, 2019

Authors:

Edward V. Loftus

Walter Reinisch

Remo Panaccione

Abstract

BACKGROUND: PYRAMID was an international multicenter, noninterventional, postmarketing registry assessing long-term safety and effectiveness of adalimumab (Humira), as used in routine clinical practice. METHODS: Adult patients with moderately to severely active Crohn's disease with or without prior ...

Subject

Adalimumab

Medicine

Internal medicine

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!